Cargando…

Effects of an Intratympanic Injection of Dexamethasone Combined with Gentamicin on the Expression Level of Serum P0 Protein Antibodies in Patients with Meniere’s Disease

OBJECTIVES: To investigate the effects of an intratympanic injection of dexamethasone combined with gentamicin on the expression level of serum P0 protein antibodies in patients with Meniere’s disease (MD). METHODS: A total of 136 patients with MD treated in our hospital were enrolled in this study....

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Yang, Cao, Wenping, Xu, Huijuan, Wu, Fengfang, Feng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688074/ https://www.ncbi.nlm.nih.gov/pubmed/33263629 http://dx.doi.org/10.6061/clinics/2020/e1622

Ejemplares similares

Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
por: Guan, Yafeng, et al.
Publicado: (2021)

Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019)

Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease
por: Dabiri Satri, Sasan, et al.
Publicado: (2017)

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
por: Memari, Faramarz, et al.
Publicado: (2014)

Intratympanic corticosteroids for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Correction: Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
Publicado: (2014)

Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022)

One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings
por: Daneshi, Ahmad, et al.
Publicado: (2014)

Use of Skull Vibration-Induced Nystagmus in the Follow-up of Patients With Ménière Disease Treated With Intratympanic Gentamicin
por: Alonso, Susana Marcos, et al.
Publicado: (2023)

Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature
por: Walther, L. E., et al.
Publicado: (2013)

Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy
por: Molnár, András, et al.
Publicado: (2021)

Consensus on intratympanic drug delivery for Menière’s disease
por: Li, Shuna, et al.
Publicado: (2022)

Editorial: Intratympanic and surgical treatment for Meniere's disease
por: Yang, Jun, et al.
Publicado: (2022)

Intratympanic corticosteroids in Ménière's disease: A mini-review
por: Patel, Mitesh
Publicado: (2017)

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone
por: Le, Thi Phuc, et al.
Publicado: (2023)

Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020)

Intratympanic dexamethasone injection for sudden sensorineural hearing loss in pregnancy
por: Lyu, Yan-Lu, et al.
Publicado: (2020)

Clinical Analysis of Intratympanic Injection of Dexamethasone for Treating Sudden Deafness
por: Li, Xin, et al.
Publicado: (2021)

Skull-vibration-induced nystagmus test in patients who are candidates for intratympanic gentamicin injection
por: Ciacca, Giacomo, et al.
Publicado: (2023)

Intratympanic Gentamicin Versus Labyrinthectomy: Inner Ear Sensitivity to Gentamicin and Impact on the Contralateral Labyrinth
por: Kontorinis, Georgios, et al.
Publicado: (2019)

Contralateral spreading of substances following intratympanic nanoparticle-conjugated gentamicin injection in a rat model
por: Lee, Sang-Yeon, et al.
Publicado: (2020)

Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study
por: Bremer, Hendrik G, et al.
Publicado: (2014)

Low-Dose Intratympanic Gentamicin for Unilateral Ménière‘s Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome
por: Wegmann-Vicuña, Ricardo, et al.
Publicado: (2022)

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss
por: Jung, So-Young, et al.
Publicado: (2021)

Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial
por: Lambert, Paul R., et al.
Publicado: (2016)

Intratympanic Lipopolysaccharide Elevates Systemic Fluorescent Gentamicin Uptake in the Cochlea
por: Chai, Yongchuan, et al.
Publicado: (2021)

Systemic effects of intratympanic dexamethasone therapy
por: Novoa, Eva, et al.
Publicado: (2014)

MRI With Intratympanic Gadolinium: Comparison Between Otoneurological and Radiological Investigation in Menière's Disease
por: Neri, Giampiero, et al.
Publicado: (2021)

Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss
por: Yoshida, Tadao, et al.
Publicado: (2012)

A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy
por: Cioffi, Giacomo Maria, et al.
Publicado: (2019)

Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease
por: Fukuoka, Hisakuni, et al.
Publicado: (2012)

Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study
por: Liu, Bo, et al.
Publicado: (2016)

Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
por: Berjis, Nezamoddin, et al.
Publicado: (2016)

Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis
por: Chung, Juyong, et al.
Publicado: (2022)

Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant cases
por: Ismaiel, Wael F., et al.
Publicado: (2022)

Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials()()
por: Celis-Aguilar, Erika, et al.
Publicado: (2016)

The Effect of Intracochlear and Intratympanic Dexamethasone on Cochlear Implant Impedance
por: Ardıç, Fazıl Necdet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2qcme6jhhveee99loadlbtr60h